News & Events
News
Fibralign Sponsors International Research Seminar
Fibralign is hosting the inaugural Lymphedema Summit on January 23- Fibralign is hosting the inaugural Lymphedema Summit on January 23, an international research seminar focused on “Advancements in Lymphedema Surgical Treatment.” For more details:...
Fibralign Selected as a UCSF Rosenman Institute Innovator
NCI-funded study evaluating Fibralign’s BioBridge® as an adjunct to microsurgical treatment SAN FRANCISCO, June 10, 2021 /PRNewswire/ -- The UCSF Rosenman Institute is proud to announce the 2021 cohort of the Rosenman Innovators, a group of early-stage health...
UChicago Medicine Enrolling Patients in Lymphbridge™ Clinical Study For Surgical Treatment Of Breast Cancer-Related Lymphedema
NCI-funded study evaluating Fibralign’s BioBridge® as an adjunct to microsurgical treatment April 14, 2021 – The University of Chicago Medicine has announced today that it is now enrolling patients into LymphBridge™, a randomized clinical study to evaluate a...
Conferences
Fibralign and its research collaborators have made over 50 presentations related to BioBridge and Nanoweave scientific findings at international leading medical research conferences over the previous two years.
While these conferences have largely paused during 2020 due to the pandemic, we will post upcoming presentations when these conferences return to schedule.
